Previous Section
Treatment of Chronic Myelogenous Leukemia
Transplantation-Based Therapies for Chronic Myelogenous Leukemia
In general, reduced-intensity transplants are usually reserved for patients over age 60 or patients who cannot otherwise tolerate a standard allogeneic SCT. Currently, there is no general consensus among transplant centers regarding the most optimal reduced-intensity preparatory regimen to use prior to transplantation and this remains an area of active research.
